ABSTRACT
BACKGROUND: Influenced by the global aging population, the incidence of Alzheimer's disease (AD) has increased sharply. In addition to increasing ß-amyloid plaque deposition and tau tangle formation, neurogenesis dysfunction has recently been observed in AD. Therefore, promoting regeneration to improve neurogenesis and cognitive dysfunction can play an effective role in AD treatment. Acupuncture and moxibustion have been widely used in the clinical treatment of neurodegenerative diseases because of their outstanding advantages such as early, functional, and benign two-way adjustment. It is urgent to clarify the effectiveness, greenness, and safety of acupuncture and moxibustion in promoting neurogenesis in AD treatment. METHODS: Senescence-accelerated mouse prone 8 (SAMP8) mice at various ages were used as experimental models to simulate the pathology and behaviors of AD mice. Behavioral experiments, immunohistochemistry, Western blot, and immunofluorescence experiments were used for comparison between different groups. RESULTS: Acupuncture and moxibustion could increase the number of PCNA+ DCX+ cells, Nissl bodies, and mature neurons in the hippocampal Dentate gyrus (DG) of SAMP8 mice, restore the hippocampal neurogenesis, delay the AD-related pathological presentation, and improve the learning and memory abilities of SAMP8 mice. CONCLUSION: The pathological process underlying AD and cognitive impairment were changed positively by improving the dysfunction of neurogenesis. This indicates the promising role of acupuncture and moxibustion in the prevention and treatment of AD.
Subject(s)
Acupuncture Therapy , Alzheimer Disease , Moxibustion , Mice , Animals , Alzheimer Disease/therapy , Alzheimer Disease/pathology , Hippocampus/pathology , Neurogenesis/physiology , Dentate Gyrus/pathology , Disease Models, AnimalABSTRACT
BACKGROUND: Impaired pattern separation occurs in the early stage of Alzheimer's disease (AD), and hippocampal dentate gyrus (DG) neurogenesis participates in pattern separation. Here, we investigated whether spatial memory discrimination impairment can be improved by promoting the hippocampal DG granule cell neogenesis-mediated pattern separation in the early stage of AD by electroacupuncture (EA). METHODS: Five familial AD mutations (5 × FAD) mice received EA treatment at Baihui and Shenting points for 4 weeks. During EA, mice were intraperitoneally injected with BrdU (50 mg/kg) twice a day. rAAV containing Wnt5a shRNA was injected into the bilateral DG region, and the viral efficiency was evaluated by detecting Wnt5a mRNA levels. Cognitive behavior tests were conducted to assess the impact of EA treatment on cognitive function. The hippocampal DG area Aß deposition level was detected by immunohistochemistry after the intervention; The number of BrdU+/CaR+ cells and the gene expression level of calretinin (CaR) and prospero homeobox 1(Prox1) in the DG area of the hippocampus was detected to assess neurogenesis by immunofluorescence and western blotting after the intervention; The gene expression levels of FZD2, Wnt5a, DVL2, p-DVL2, CaMKII, and p-CaMKII in the Wnt signaling pathway were detected by Western blotting after the intervention. RESULTS: Cognitive behavioral tests showed that 5 × FAD mice had impaired pattern separation (P < 0.001), which could be improved by EA (P < 0.01). Immunofluorescence and Western blot showed that the expression of Wnt5a in the hippocampus was decreased (P < 0.001), and the neurogenesis in the DG was impaired (P < 0.001) in 5 × FAD mice. EA could increase the expression level of Wnt5a (P < 0.05) and promote the neurogenesis of immature granule cells (P < 0.05) and the development of neuronal dendritic spines (P < 0.05). Interference of Wnt5a expression aggravated the damage of neurogenesis (P < 0.05), weakened the memory discrimination ability (P < 0.05), and inhibited the beneficial effect of EA (P < 0.05) in AD mice. The expression level of Wnt pathway related proteins such as FZD2, DVL2, p-DVL2, CAMKII, p-CAMKII increased after EA, but the effect of EA was inhibited after Wnt5a was knocked down. In addition, EA could reduce the deposition of Aß plaques in the DG without any impact on Wnt5a. CONCLUSION: EA can promote hippocampal DG immature granule cell neogenesis-mediated pattern separation to improve spatial memory discrimination impairment by regulating Wnt5a in 5 × FAD mice.
Subject(s)
Alzheimer Disease , Electroacupuncture , Mice , Animals , Alzheimer Disease/therapy , Alzheimer Disease/metabolism , Bromodeoxyuridine , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Hippocampus/metabolism , Disease Models, Animal , Neurogenesis , Dentate Gyrus/metabolismABSTRACT
There has been considerable speculation regarding the function of the dentate gyrus (DG) - a subregion of the mammalian hippocampus - in learning and memory. In this Perspective article, we compare leading theories of DG function. We note that these theories all critically rely on the generation of distinct patterns of activity in the region to signal differences between experiences and to reduce interference between memories. However, these theories are divided by the roles they attribute to the DG during learning and recall and by the contributions they ascribe to specific inputs or cell types within the DG. These differences influence the information that the DG is thought to impart to downstream structures. We work towards a holistic view of the role of DG in learning and memory by first developing three critical questions to foster a dialogue between the leading theories. We then evaluate the extent to which previous studies address our questions, highlight remaining areas of conflict, and suggest future experiments to bridge these theories.
Subject(s)
Dentate Gyrus , Hippocampus , Animals , Humans , Mental Recall , Learning , MammalsABSTRACT
A growing body of evidence suggests that hyperbaric oxygenation (HBO) may affect the activity of adult neural stem cells (NSCs). Since the role of NSCs in recovery from brain injury is still unclear, the purpose of this study was to investigate the effects of sensorimotor cortex ablation (SCA) and HBO treatment (HBOT) on the processes of neurogenesis in the adult dentate gyrus (DG), a region of the hippocampus that is the site of adult neurogenesis. Ten-week-old Wistar rats were divided into groups: Control (C, intact animals), Sham control (S, animals that underwent the surgical procedure without opening the skull), SCA (animals in whom the right sensorimotor cortex was removed via suction ablation), and SCA + HBO (operated animals that passed HBOT). HBOT protocol: pressure applied at 2.5 absolute atmospheres for 60 min, once daily for 10 days. Using immunohistochemistry and double immunofluorescence labeling, we show that SCA causes significant loss of neurons in the DG. Newborn neurons in the subgranular zone (SGZ), inner-third, and partially mid-third of the granule cell layer are predominantly affected by SCA. HBOT decreases the SCA-caused loss of immature neurons, prevents reduction of dendritic arborization, and increases proliferation of progenitor cells. Our results suggest a protective effect of HBO by reducing the vulnerability of immature neurons in the adult DG to SCA injury.
Subject(s)
Brain Injuries , Hyperbaric Oxygenation , Neural Stem Cells , Rats , Animals , Rats, Wistar , Neural Stem Cells/physiology , Hippocampus , Neurons/physiology , Neurogenesis/physiology , Dentate GyrusABSTRACT
Aluminum (Al) is known to induce neurotoxicity in both humans and rodents. Recent evidence has indicated that the toxicity of Al Oxide (Al2O3) nanoparticles (Al-NP), one of the most abundantly used engineered nanoparticles, is far greater than that of Al itself. To date, however, no information is available regarding the effect of Al-NP on the stereological parameters of hippocampus. In particular, no stereological studies have evaluated the effect of Al-NP on hippocampal CA1, dentate gyrus volume, and number of pyramidal and granular cells. Thus, the present study aimed to take a multidimensional approach to assess the concomitant cognitive, stereological, and apoptotic changes induced by a five-day Al-NP ingestion (10 mg/kg/day) in mice. The results demonstrated that the five-day Al-NP ingestion elicited a reduced preference to explore a novel object in the novel object recognition test (a hippocampal-dependent task). Perhaps contributing to this memory deficit, Al-NP induced additional alterations in the hippocampus of male NMRI mice in terms of (1) hippocampal volume (decreased the volume of the whole hippocampus, CA1, and dentate gyrus regions), (2) cell number (decreased the number of CA1 pyramidal neurons and dentate gyrus granular cells), and (3) increased cleaved caspase-3 in the whole hippocampus. These results provided new mechanistic insight to understand the impairing effect of AL-NP on the hippocampal function and structure.
Subject(s)
Cognitive Dysfunction , Neurons , Aluminum Oxide/toxicity , Animals , Cognitive Dysfunction/chemically induced , Dentate Gyrus , Hippocampus , Humans , Male , Mice , Pyramidal CellsABSTRACT
Astrocytes and microglia are the first cells to react to neurodegeneration, e.g., in Alzheimer's disease (AD); however, the data on changes in glial support during the most common (sporadic) type of the disease are sparse. Using senescence-accelerated OXYS rats, which simulate key characteristics of sporadic AD, and Wistar rats (parental normal strain, control), we investigated hippocampal neurogenesis and glial changes during AD-like pathology. Using immunohistochemistry, we showed that the early stage of the pathology is accompanied by a lower intensity of neurogenesis and decreased astrocyte density in the dentate gyrus. The progressive stage is concurrent with reactive astrogliosis and microglia activation, as confirmed by increased cell densities and by the acquisition of cell-specific gene expression profiles, according to transcriptome sequencing data. Besides, here, we continued to analyze the anti-AD effects of prolonged supplementation with mitochondria-targeted antioxidant SkQ1. The antioxidant did not affect neurogenesis, partly normalized the gene expression profile of astrocytes and microglia, and shifted the resting/activated microglia ratio toward a decrease in the activated-cell density. In summary, both astrocytes and microglia are more vulnerable to AD-associated neurodegeneration in the CA3 area than in other hippocampal areas; SkQ1 had an anti-inflammatory effect and is a promising modality for AD prevention and treatment.
Subject(s)
Alzheimer Disease/diet therapy , Alzheimer Disease/pathology , Dentate Gyrus/pathology , Plastoquinone/analogs & derivatives , Alzheimer Disease/etiology , Alzheimer Disease/genetics , Animals , Astrocytes/chemistry , Astrocytes/drug effects , Astrocytes/pathology , Dentate Gyrus/chemistry , Dentate Gyrus/drug effects , Dietary Supplements , Disease Models, Animal , Gene Expression Profiling , Gene Expression Regulation/drug effects , Male , Mitochondria/drug effects , Mitochondria/genetics , Plastoquinone/administration & dosage , Plastoquinone/pharmacology , Rats , Rats, WistarABSTRACT
We have recently shown that folate deficiency induces depression-like behavior and neuronal immaturity in the dentate gyrus (DG) in mice. We also revealed that folate deficiency inhibits neuronal maturation, hypomethylates the promoter of certain neuronal genes and decreases intracellular levels of S-adenosylmethionine (SAM), a methyl donor, in cultured neural stem and progenitor cells. Based on these findings, we hypothesized that SAM reduction may be involved in a folate deficiency-induced depressive state and neural immaturity. In this study, we examined whether SAM supplementation prevents depression-like behavior and neural immaturity in low folate diet-fed mice. Intraperitoneal administration of SAM (50 mg/kg/day) for 14 days from 7 weeks old prevented increased immobility in low folate diet-fed mice. SAM supplementation also prevented an increase in the number of doublecortin (an immature neuron marker)-positive cells and a decrease in the number of NeuN (a mature neuron marker)/5-bromo-2'-deoxyuridine (a proliferation marker)-double positive cells in the DG of these mice. Furthermore, neurofunctional and neuromorphological abnormalities in the DG of low folate diet-fed mice, such as decreases in stress-induced expression of c-Fos (a neuronal activity marker), dendritic complexity and the number of mature spines, were improved by SAM supplementation. The disrupted expression of transcription factors involved in neuronal differentiation and maturation was also normalized by SAM supplementation. These results suggest that SAM reduction may be involved in a folate deficiency-induced depressive state.
Subject(s)
Depression , Neurons , Animals , Dentate Gyrus , Depression/prevention & control , Dietary Supplements , Folic Acid , Mice , Neurons/metabolismABSTRACT
Choline is an essential nutrient under evaluation as a cognitive enhancing treatment for fetal alcohol spectrum disorders (FASD) in clinical trials. As a result, there is increased pressure to identify therapeutic mechanism(s) of action. Choline is not only a precursor for several essential cell membrane components and signaling molecules but also has the potential to directly affect synaptic mechanisms that are believed important for cognitive processes. In the current work, we study how the direct application of choline can affect synaptic transmission in the dentate gyrus (DG) of hippocampal slices obtained from adolescent (postnatal days 21-28) Sprague-Dawley rats (Rattus norvegicus). The acute administration of choline chloride (2 mM) reliably induced a long-term depression (LTD) of field excitatory postsynaptic potentials (fEPSPs) in the DG in vitro. The depression required the involvement of M1 receptors, and the magnitude of the effect was similar in slices obtained from male and female animals. To further study the impact of choline in an animal model of FASD, we examined offspring from dams fed an ethanol-containing diet (35.5% ethanol-derived calories) throughout gestation. In slices from the adolescent animals that experienced prenatal ethanol exposure (PNEE), we found that the choline induced an LTD that uniquely involved the activation of N-methyl-d-aspartate (NMDA) and M1 receptors. This study provides a novel insight into how choline can modulate hippocampal transmission at the level of the synapse and that it can have unique effects following PNEE.NEW & NOTEWORTHY Choline supplementation is a nutraceutical therapy with significant potential for a variety of developmental disorders; however, the mechanisms involved in its therapeutic effects remain poorly understood. Our research shows that choline directly impacts synaptic communication in the brain, inducing a long-term depression of synaptic efficacy in brain slices. The depression is equivalent in male and female animals, involves M1 receptors in control animals, but uniquely involves NMDA receptors in a model of FASD.
Subject(s)
Central Nervous System Depressants/pharmacology , Choline/pharmacology , Dentate Gyrus/drug effects , Ethanol/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Fetal Alcohol Spectrum Disorders/physiopathology , Long-Term Synaptic Depression/drug effects , Nootropic Agents/pharmacology , Prenatal Exposure Delayed Effects/physiopathology , Receptor, Muscarinic M1/drug effects , Receptors, N-Methyl-D-Aspartate/drug effects , Synaptic Transmission/drug effects , Animals , Disease Models, Animal , Female , Male , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Rats , Rats, Sprague-DawleyABSTRACT
Mild cognitive impairment (MCI) designates the boundary area between cognitive function in natural aging and dementia, and this is viewed as a therapeutic window to prevent the occurrence of dementia. The current study investigated the neurocognitive effects of oral creatine (Cr) supplementation in young female Wistar rats that received intracerebroventricular injections of lipopolysaccharide (LPS) to mimic MCI. Neuromolecular changes within the dentate gyrus were analyzed following behavioral testing. We also investigated both neurocognitive and neuromolecular changes following Cr supplementation in the absence of LPS in young female Wistar rats to further investigate mechanisms. Interestingly, based on trial 2 of Barnes maze test, Cr supplementation ameliorated spatial learning and memory deficit induced by LPS, shown by decreased latency time and errors to reach the escape box (p < 0.0001, n = 12). Cr supplementation also attenuated recognition memory deficit induced by LPS, shown by increased amount of time taken to explore the new object (p = 0.002, n = 12) during novel object recognition testing. Within the dentate gyrus, Cr supplementation in LPS injected rats upregulated mTORC1 signaling (p = 0.026 for mTOR phosphorylation, p = 0.002 for p70S6K phosphorylation, n = 8) as well as the synapsin (p = 0.008) and PSD-95 synaptic proteins (p = 0.015), in comparisons to LPS injected rats. However, Cr supplementation failed to further enhance spatial memory and recognition memory in the absence of LPS. In conclusion, Cr ameliorates LPS-induced cognitive impairment in a rodent MCI model. Mechanistically, these phenotypic effects may, in part, be mitigated via an upregulation of mTORC1 signaling, and an enhancement in synaptogenesis in the dentate gyrus. While preliminary, these findings may inform future research investigating neurocognitive effects of Cr for MCI patients.
Subject(s)
Cognitive Dysfunction/drug therapy , Creatine/administration & dosage , Dentate Gyrus/metabolism , Dietary Supplements , Memory Disorders/drug therapy , Animal Nutritional Physiological Phenomena/drug effects , Animals , Behavior, Animal/drug effects , Cognitive Dysfunction/chemically induced , Disease Models, Animal , Female , Lipopolysaccharides , Maze Learning , Mechanistic Target of Rapamycin Complex 1/metabolism , Memory Disorders/chemically induced , Neuronal Plasticity/drug effects , Rats , Rats, Wistar , Recognition, Psychology/drug effects , Signal Transduction/drug effects , Spatial Memory/drug effects , Up-Regulation/drug effectsABSTRACT
Ninjin-yoei-to (NYT), a Kampo medicine, has ameliorative effects on cognitive dysfunction via enhancing cholinergic neuron activity. To explore an efficacy of NYT administration for prevention and cure of Alzheimer's disease, here we examined the effect of NYT on amyloid ß1-42 (Aß1-42)-induced neurodegeneration in the dentate gyrus. A diet containing 3% NYT was administered to mice for 2 weeks and human Aß1-42 was intracerebroventricularly injected. Neurodegeneration in the dentate granule cell layer of the hippocampus, which was determined 2 weeks after the injection, was rescued by administration of the diet for 4 weeks. Aß staining (uptake) was not modified in the dentate granule cell layer by pre-administration of the diet for 2 weeks, while Aß1-42-induced increase in intracellular Zn2+ was reduced, suggesting that pre-administration of NYT prior to Aß injection is effective for reducing Aß1-42-induced Zn2+ toxicity in the dentate gyrus. As a matter of fact, Aß1-42-induced neurodegeneration in the dentate gyrus was rescued by pre-administration of NYT. Interestingly, the level of metallothioneins, intracellular Zn2+-binding proteins, which can capture Zn2+ from Zn-Aß1-42 complexes, was elevated in the dentate granule cell layer by pre-administration of NYT. The present study suggests that pre-administration of NYT prevents Aß1-42-mediated neurodegeneration in the dentate gyurs by induced synthesis of metallothioneins, which reduces intracellular Zn2+ toxicity induced by Aß1-42.
Subject(s)
Amyloid beta-Peptides/pharmacology , Cognitive Dysfunction/drug therapy , Dentate Gyrus/physiopathology , Medicine, Kampo , Panax/chemistry , Protective Agents/pharmacology , Animals , Dentate Gyrus/drug effects , Male , MiceABSTRACT
Aspilia africana is an herbal plant widespread in Africa used for medicinal purposes and also used by pregnant women for health related issues. This study was aimed at investigating the teratogenic effect of aqueous leaf extract of Aspilia africana on the dentate gyrus of albino wistar rat fetuses. Twenty (20) female adult rats weighing between 190-205g were used for this study. The rats were divided into four groups; control, low dose, medium dose and high dose with each group containing five rats. Pregnancy was induced by caging the female rats with sexually matured males. The presence of vaginal plug and tail structure in the vaginal smear the following morning confirmed coition, and it was regarded as day 0 of pregnancy. The control group was given distilled water. The low dose, medium dose, and the high dose groups received 750mg/kg, 1000mg/kg, and 1250mg/kg body weight of aqueous leaf extract of Aspilia africana through an orogastric tube from day 7-11 of gestation. On the 20th day of gestation, the animals were sacrificed using chloroform-inhalation method. Their fetuses were harvested via uterectomy, the brain was excised and fixed in 10% buffered formalin, and then routine histological processes were carried out. Staining was done using Haematoxylin and Eosin method. Histological observation of the dentate gyri of experimental groups revealed marked distortion, reduction of the polymorphic layer, hyperplasia and hypertrophy of cells in the molecular and granular layer especially in the high dose group whose mothers received 1250mg/kg of the extracts. The result suggests high doses of aqueous leaf extract of Aspilia africana may be teratogenic to the dentate gyrus of Wistar rat fetuses.
Subject(s)
Asteraceae , Animals , Asteraceae/chemistry , Dentate Gyrus , Female , Fetus , Humans , Male , Plant Extracts/pharmacology , Pregnancy , Rats , Rats, Wistar , WaterABSTRACT
The burden of depression is enormous, and numerous studies have found that major depressive disorder (MDD) induces cardiovascular disorders (CVD) and functional dyspepsia (FD). Excitingly, meranzin hydrate (MH), an absorbed bioactive compound of Aurantii Fructus Immaturus, reverses psychosocial stress-induced mood disorders, gastrointestinal dysfunction and cardiac disease. Pharmacological methods have repeatedly failed in antidepressant development over the past few decades, but repairing aberrant neural circuits might be a reasonable strategy. This article aimed to explore antidepressant-like effects and potential mechanisms of MH in a rat model of unpredictable chronic mild stress (UCMS). Utilizing blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI), we sought to find reliable neurocircuits or a dominant brain region revealing the multiple effects of MH. The results show that compared with UCMS rats, MH (10 mg/kg/day for 1 week i.g.)-treated rats exhibited decreased depression-like behaviour; increased expression of brain-derived neurotrophic factor (BDNF) in the hippocampal dentate gyrus; and normalized levels of adrenocorticotropic hormone (ACTH), corticosterone (CORT), and acylated ghrelin (AG). Additionally, the UCMS-induced rise in BOLD activation in the reward system was attenuated after MH treatment. A literature search shown that nucleus accumbens (NAc) and hypothalamus of the reward system might reveal multiple effects of MH on MDD-FD-CVD comorbidity. Further research will focus on the role of these two brain regions in treating depression associated with comorbidities.
Subject(s)
Antidepressive Agents/pharmacology , Coumarins/pharmacology , Dentate Gyrus/drug effects , Depression/drug therapy , Drugs, Chinese Herbal , Hypothalamo-Hypophyseal System/drug effects , Reward , Stress, Psychological/drug therapy , Animals , Antidepressive Agents/administration & dosage , Behavior, Animal/drug effects , Brain-Derived Neurotrophic Factor/drug effects , Coumarins/administration & dosage , Dentate Gyrus/metabolism , Disease Models, Animal , Hypothalamo-Hypophyseal System/metabolism , Male , Rats , Rats, WistarABSTRACT
Amyloid ß-peptides (Aß) are considered as a major hallmark of Alzheimer's disease (AD) that can induce synaptic loss and apoptosis in brain regions, particularly in the cortex and the hippocampus. Evidence suggests that crocin, as the major component of saffron, can exhibit neuromodulatory effects in AD. However, specific data related to their efficacy to attenuate the synaptic loss and neuronal death in animal models of AD are limited. Hence, we investigated the efficacy of crocin in the CA3 and dentate gyrus (DG) regions of the hippocampus and also in frontal cortex neurons employing a rat model of AD. Male Wistar rats were randomly divided into control, sham, AD model, crocin, and AD model + crocin groups, with 8 rats per group. AD model was established by injecting Aß1-42 into the frontal cortex rats, and thereafter the rats were administrated by crocin (30 mg/kg) for a duration of 12-day. The number of live cells, neuronal arborization and apoptosis were measured using a Cresyl violet, Golgi-Cox and TUNEL staining, respectively. Results showed that, the number of live cells in the hippocampus pyramidal neurons in the CA3 and granular cells in the DG regions of the AD rats significantly decreased, which was significantly rescued by crocin. Compared with the control group, the axonal, spine and dendrites arborization in the frontal cortex and CA3 region of the AD model group significantly decreased. The crocin could significantly reverse this arborization loss in the AD rats (P < 0.05). The apoptotic cell number in the CA3 and DG regions in the AD model group was significantly higher than that of the control group (P < 0.05), while crocin significantly decreased the apoptotic cell number in the AD group (P < 0.05). Conclusion. Crocin can improve the synaptic loss and neuronal death of the AD rats possibly by reducing the neuronal apoptosis.
Subject(s)
Alzheimer Disease/pathology , CA3 Region, Hippocampal/drug effects , Carotenoids/pharmacology , Dentate Gyrus/drug effects , Frontal Lobe/drug effects , Pyramidal Cells/drug effects , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Animals , Apoptosis/drug effects , CA3 Region, Hippocampal/metabolism , CA3 Region, Hippocampal/pathology , Dentate Gyrus/metabolism , Dentate Gyrus/pathology , Disease Models, Animal , Frontal Lobe/metabolism , Frontal Lobe/pathology , Male , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , Rats , Rats, WistarABSTRACT
RATIONALE: Autism spectrum disorders (ASDs) are highly prevalent neurodevelopmental disorders characterized by deficits in social communication and interaction, repetitive stereotyped behaviors, and cognitive impairments. Curcumin has been indicated to be neuroprotective against neurological and psychological disorders. However, the role of curcumin in autistic phenotypes remains unclear. OBJECTIVES: In the current study, we evaluated the effects of neonatal curcumin treatment on behavior and hippocampal neurogenesis in BTBRT+ltpr3tf/J (BTBR) mice, a model of autism. METHODS: C57BL/6J (C57) and BTBR mouse pups were treated with 0.1% dimethyl sulfoxide (DMSO) or curcumin (20 mg/kg) from postnatal day 6 (P6) to P8. Neural progenitor cells (NPCs) in the hippocampal dentate gyrus (DG) were evaluated on P8, and neurogenesis was measured on P24 by immunofluorescence. A battery of behavioral tests was carried out when the mice were 8 weeks of age. RESULTS: Neonatal curcumin treatment improved autism-related symptoms in BTBR mice, enhancing sociability, reducing repetitive behaviors, and ameliorating cognitive impairments. Furthermore, the suppression of hippocampal neurogenesis in BTBR mice was greatly rescued after neonatal curcumin treatment, leading to an increase in neurogenic processes and an increase in NPC proliferation concomitant with an expansion of the NPC pool on P8, and NPC differentiation towards the neuronal lineage was promoted in the DG of BTBR mice on P24. CONCLUSIONS: Our findings suggest that neonatal curcumin treatment elicits a therapeutic response through the restoration of hippocampal neurogenesis in BTBR mice and thus may represent a promising novel pharmacological strategy for ASD treatment.
Subject(s)
Autism Spectrum Disorder/prevention & control , Behavior, Animal/drug effects , Curcumin/pharmacology , Dentate Gyrus/drug effects , Neurogenesis/drug effects , Neuroprotective Agents/pharmacology , Animals , Animals, Newborn , Autism Spectrum Disorder/psychology , Cell Proliferation/drug effects , Dentate Gyrus/growth & development , Disease Models, Animal , Male , Mice , Mice, Inbred C57BL , Neural Stem Cells/drug effects , Social BehaviorABSTRACT
Functional ultrasound (fUS) is a new tool enabling the imaging of brain activity through the regional monitoring of cerebral blood volume (CBV) dynamics. This innovative technique has not yet demonstrated its full potential in pharmacological applications and drug development. In the current proof-of-concept study, the impact of atomoxetine (ATX), a potent norepinephrine reuptake inhibitor and non-stimulant treatment marketed in attention-deficit/hyperactivity-disorder, was evaluated in anesthetized rat using pharmacological functional ultrasound (pharmaco-fUS) at increasing doses (0.3, 1 and 3 mg/kg). Using regions of interest (acute changes of CBV and functional connectivity) or pixel-based (general linear modeling and independent component analysis) analysis, we here demonstrated that ATX consistently displayed a hemodynamic effect in the visual cortex, the dentate gyrus and thalamus, especially visual areas such as lateral posterior thalamic nuclei and lateral geniculate nuclei (LGN). The time profile of ATX effects was dose-dependent, with fastest CBV increases at the highest dose, and longer CBV increases at the intermediate dose. Standardizing the use of pharmaco-fUS could improve our understanding of the mechanism of action of drugs active in the brain and might constitute a new step to move forward in drug development for neurological disorders.
Subject(s)
Adrenergic Uptake Inhibitors/metabolism , Atomoxetine Hydrochloride/metabolism , Dentate Gyrus/metabolism , Thalamus/metabolism , Ultrasonography/methods , Visual Cortex/metabolism , Adrenergic Uptake Inhibitors/pharmacology , Animals , Atomoxetine Hydrochloride/pharmacology , Dentate Gyrus/diagnostic imaging , Dentate Gyrus/drug effects , Male , Rats , Rats, Inbred WKY , Thalamus/diagnostic imaging , Thalamus/drug effects , Visual Cortex/diagnostic imaging , Visual Cortex/drug effectsABSTRACT
Major depressive disorder (MDD) is a leading cause of morbidity, and the fourth leading cause of disease burden worldwide. While MDD is a treatable condition for many individuals, others suffer from treatment-resistant depression (TRD). Here, we suggest the immunomodulatory compound AS101 as novel therapeutic alternative. We previously showed in animal models that AS101 reduces anxiety-like behavior and elevates levels of the brain-derived neurotrophic factor (BDNF), a protein that has a key role in the pathophysiology of depression. To explore the potential antidepressant properties of AS101, we used the extensively characterized chronic mild stress (CMS) model, and the depressive rat line (DRL Finally, in Exp. 3 to attain insight into the mechanism we knocked down BDNF in the hippocampus, and demonstrated that the beneficial effect of AS101 was abrogated. Together with the previously established safety profile of AS101 in humans, these results may represent the first step towards the development of a novel treatment option for MDD and TRD.
Subject(s)
Antidepressive Agents/therapeutic use , Brain-Derived Neurotrophic Factor/physiology , Depressive Disorder/drug therapy , Disease Models, Animal , Ethylenes/therapeutic use , Hippocampus/drug effects , Immunologic Factors/therapeutic use , Animals , Antidepressive Agents/chemistry , Brain-Derived Neurotrophic Factor/antagonists & inhibitors , Dentate Gyrus/drug effects , Dentate Gyrus/metabolism , Depressive Disorder/etiology , Depressive Disorder/genetics , Drug Evaluation, Preclinical , Ethylenes/chemistry , Exploratory Behavior/drug effects , Gene Knockdown Techniques , Hippocampus/metabolism , Immunologic Factors/chemistry , Male , Motor Activity/drug effects , Open Field Test , RNA Interference , RNA, Small Interfering/genetics , Rats , Rats, Sprague-Dawley , Stress, Physiological , Sucrose , SwimmingABSTRACT
Vitamin D is an essential fat-soluble vitamin that participates in several homeostatic functions in mammalian organisms. Lower levels of vitamin D are produced in the older population, vitamin D deficiency being an accelerating factor for the progression of the aging process. In this review, we focus on the effect that vitamin D exerts in the aged brain paying special attention to the neurogenic process. Neurogenesis occurs in the adult brain in neurogenic regions, such as the dentate gyrus of the hippocampus (DG). This region generates new neurons that participate in cognitive tasks. The neurogenic rate in the DG is reduced in the aged brain because of a reduction in the number of neural stem cells (NSC). Homeostatic mechanisms controlled by the Wnt signaling pathway protect this pool of NSC from being depleted. We discuss in here the crosstalk between Wnt signaling and vitamin D, and hypothesize that hypovitaminosis might cause failure in the control of the neurogenic homeostatic mechanisms in the old brain leading to cognitive impairment. Understanding the relationship between vitamin D, neurogenesis and cognitive performance in the aged brain may facilitate prevention of cognitive decline and it can open a door into new therapeutic fields by perspectives in the elderly.
Subject(s)
Aging/physiology , Cognitive Dysfunction/epidemiology , Dentate Gyrus/growth & development , Neurogenesis/physiology , Vitamin D Deficiency/epidemiology , Wnt Signaling Pathway/physiology , Animals , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/prevention & control , Dentate Gyrus/cytology , Dentate Gyrus/metabolism , Dentate Gyrus/physiopathology , Dietary Supplements , Disease Models, Animal , Humans , Neural Stem Cells/physiology , Risk Factors , Time Factors , Vitamin D/administration & dosage , Vitamin D/metabolism , Vitamin D Deficiency/diet therapy , Vitamin D Deficiency/physiopathologyABSTRACT
Bacopa monnieri L. Wettst. (BM) is a botanical component of Ayurvedic medicines and of dietary supplements used worldwide for cognitive health and function. We previously reported that administration of BM alcoholic extract (BME) prevents trimethyltin (TMT)-induced cognitive deficits and hippocampal cell damage and promotes TMT-induced hippocampal neurogenesis. In this study, we demonstrate that administration of BME improves spatial working memory in adolescent (5-week- old) healthy mice but not adult (8-week-old) mice. Moreover, improved spatial working memory was retained even at 4 weeks after terminating 1-week treatment of adolescent mice. One-week BME treatment of adolescent mice significantly enhanced hippocampal BrdU incorporation and expression of genes involved in neurogenesis determined by RNAseq analysis. Cell death, as detected by histochemistry, appeared not to be significant. A significant increase in neurogenesis was observed in the dentate gyrus region 4 weeks after terminating 1-week treatment of adolescent mice with BME. Bacopaside I, an active component of BME, promoted the proliferation of neural progenitor cells in vitro in a concentration-dependent manner via the facilitation of the Akt and ERK1/2 signaling. These results suggest that BME enhances spatial working memory in healthy adolescent mice by promoting hippocampal neurogenesis and that the effects of BME are due, in significant amounts, to bacopaside I.
Subject(s)
Bacopa/chemistry , Dentate Gyrus/drug effects , Memory Disorders/drug therapy , Memory, Short-Term/drug effects , Neurogenesis/drug effects , Nootropic Agents/therapeutic use , Plant Extracts/therapeutic use , Spatial Memory/drug effects , Animals , Cells, Cultured , DNA Replication/drug effects , Dentate Gyrus/physiopathology , Gene Expression Regulation/drug effects , Male , Maze Learning/drug effects , Medicine, Ayurvedic , Memory Disorders/chemically induced , Memory Disorders/physiopathology , Mice , Neural Stem Cells/drug effects , Neurogenesis/genetics , Nootropic Agents/pharmacology , Plant Extracts/pharmacology , RNA-Seq , Saponins/pharmacology , Sexual Maturation , Signal Transduction/drug effects , Trimethyltin Compounds/toxicity , Triterpenes/pharmacologyABSTRACT
High-fat diet (HFD) can induce deficits in neural function, oxidative stress, and decrease hippocampal neurogenesis. Hypericum (H.) scabrum extract (Ext) contains compounds that could treat neurological disorders. This study aimed to examine the neuroprotective impacts of the H. scabrum Ext on hippocampal synaptic plasticity in rats that were fed HFD. Fifty-four male Wistar rats (220 ± 10 g) were randomly arranged in six groups: (1) HFD group; (2) HFD + Ext300 group; (3) HFD + Ext100 group; (4) Control group; (5) Ext 300 mg/kg group; (6) Ext 100 mg/kg group. These protocols were administrated for 3 months. After this stage, a stimulating electrode was implanted in the perforant pathway (PP), and a bipolar recording electrode was embedded into the dentate gyrus (DG). Long-term potentiation (LTP) was provoked by high-frequency stimulation (HFS) of the PP. Field excitatory postsynaptic potentials (EPSP) and population spikes (PS) were recorded at 5, 30, and 60 min after HFS. The HFD group exhibited a large and significant decrease in their PS amplitude and EPSP slope as compared to the control and extract groups. In reverse, H. scabrum administration in the HFD + Ext rats reversed the effect of HFD on the PS amplitude and EPSP slope. The results of the study support that H. scabrum Ext can inhibit diminished synaptic plasticity caused by the HFD. These effects are probably due to the extreme antioxidant impacts of the Ext and its capability to scavenge free radicals.
Subject(s)
Brain/drug effects , Dentate Gyrus/drug effects , Diet, High-Fat/adverse effects , Hypericum/chemistry , Neuronal Plasticity/drug effects , Plant Extracts/pharmacology , Animals , Antioxidants/pharmacology , Brain/physiology , Dentate Gyrus/physiology , Disease Models, Animal , Hippocampus/drug effects , Hippocampus/physiology , Long-Term Potentiation , Male , Neuronal Plasticity/physiology , Rats , Rats, WistarABSTRACT
Schisandrin A and B (Sch A and B) are the main effective components of Schisandra chinensis (S. chinensis), which is traditionally used to enhance mental and intellectual functions in eastern Asia. Previously, we reported Sch A and B remarkably affect adult neurogenesis in the subventricular zone of mouse lateral ventricle. Since the neurogenesis in the hippocampal dentate gyrus (DG) is more important to learning, memory and cognition, here we further examined their effects on the adult DG neurogenesis. Phosphohistone H3 (PHH3) immunostaining showed that Sch B significantly enhanced the cell proliferation in the DG. Glial fibrillary acidic protein (GFAP, mostly labels astrocytes and some stem cells) staining was used to further identify the proliferating cell type. Dramatically, increases of GFAP+ cells in both Sch A and B treated groups were observed. What's more, the total numbers of the mature neurons labeled by neuron-specific nuclear protein (NeuN) were also increased in both Sch A and B treated groups compared with the controls. Together, Sch A and B enhance the adult DG neurogenesis by increasing astrocytes/stem cells and improving the survival and maturation of DG neurons. Our study shed a new light on the neuropharmacological functions of the herbal medicine S. chinensis.